Kroger Athlete's Foot Cream, Clotrimazole Cream USP, 1%, Antifungal, NET WT 0.5 OZ (15g), Distrib...
FDA Drug Recall #D-0154-2021 — Class II — November 17, 2020
Recall Summary
| Recall Number | D-0154-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 17, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Taro Pharmaceuticals U.S.A., Inc. |
| Location | Hawthorne, NY |
| Product Type | Drugs |
| Quantity | 133,452 0.5 oz tubes |
Product Description
Kroger Athlete's Foot Cream, Clotrimazole Cream USP, 1%, Antifungal, NET WT 0.5 OZ (15g), Distributed by The Kroger Co. Cincinnati, Ohio 45202 Made in Canada. NDC 30142-305-01
Reason for Recall
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
Distribution Pattern
Distributed Nationwide in the USA and Canada
Lot / Code Information
Lot#: A873430372, Exp Dec 2020; D867331278, Exp Mar 2021
Other Recalls from Taro Pharmaceuticals U.S.A., Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0633-2024 | Class III | Hydrocortisone 1% & Acetic Acid 2% Otic Solutio... | Aug 7, 2024 |
| D-0727-2022 | Class III | Clotrimazole and Betamethasone Dipropionate Cre... | Feb 25, 2022 |
| D-0375-2022 | Class I | Clobetasol Propionate Ointment USP, 0.05%, 60g ... | Dec 15, 2021 |
| D-0246-2021 | Class II | Nortriptyline HCl Capsules, USP equivalent to 1... | Jan 8, 2021 |
| D-0156-2021 | Class II | RiteAid Pharmacy RIngworm Cream, Clotrimazole C... | Nov 17, 2020 |
Frequently Asked Questions
Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.